Skip to main content
SpringerLink
Log in

A Pilot Study Reporting Outcomes for Melanoma Patients of a Minimal Access Ilio-inguinal Dissection Technique Based on Two Incisions

  • Melanomas
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

A modified procedure for ilio-inguinal regional lymph node dissection (I-I RLND) involving 2 small skin incisions was evaluated with the aim of assessing surgical and oncological noninferiority compared with the traditional single, longitudinal incision I-I RLND.

Materials and Methods

A total of 20 melanoma patients with positive groin lymph nodes who had traditional I-I RLND were compared with 20 patients who had a minimal access I-I RLND using 2 small surgical access incisions of 3–6 cm in length—one sited below and one above the inguinal ligament. Clinical, staging features, number of lymph nodes retrieved, length of hospital stay, time drains remained in situ, morbidity (wound infections, dehiscence, hematoma, seroma, and lymphedema), and disease free survival were compared.

Results

Patients in the groups were comparable with the exception that the minimal access I-I RLND group had a higher rate of AJCC stage N3 disease (60% vs 20%; P = .03) and more cases with extranodal spread (45% vs 15%; P = .041). After a median follow-up of 5 months (range 1–8) for the minimal access group and median 13 months (range 1–30) for the standard group there were no differences in disease-free survival (P = .13). Retrieved lymph node counts were similar (P = .34) including for the inguinal and pelvic components of the operations separately. No significant differences in wound complications or rates of early lymphedema were observed.

Conclusions

At early follow-up, minimal access I-I RLND is feasible and noninferior to single longitudinal incision I-I RLND in regard to surgical morbidity and oncological outcome. Further evaluation is progressing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Coit DG, Andtbacka R, Bichakjian CK, Dilawari RA, Dimaio D, Guild V, et al. Melanoma. J Natl Compr Cancer Netw. 2009;7:250–75.

    CAS  Google Scholar 

  2. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical practice guidelines for the management of melanoma in Australia and New Zealand, C.C. Australia, A.C. Network, S.A.N.Z.G. Group. Wellington, 2008.

  3. Complete Lymph Node Dissection or Observation in Treating Patients With Localized Melanoma and Sentinel Node Metastasis Who Have Undergone Sentinel Lymphadenectomy. Available from: http://clinicaltrial.gov/ct2/show/NCT00389571?term=MSLT&rank=8, July 6, 2010.

  4. MINITUB Study. Available from: http://www.melanomagroup.eu/content/view/101/117/, October 9, 2010.

  5. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet. 1998;351:793–6.

    Article  PubMed  CAS  Google Scholar 

  6. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–17.

    Article  PubMed  CAS  Google Scholar 

  7. Pasquali S, Mocellin S, Campana LG, Bonandini E, Montesco MC, Tregnaghi A, et al. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases: personal experience and literature meta-analysis. Cancer. 2010;116:1201–9.

    Article  PubMed  Google Scholar 

  8. Galliot-Repkat C, Cailliod R, Trost O, Sanino A, Collet E, Lambert D, et al. The prognostic impact of the extent of lymph node dissection in patients with stage III melanoma. Eur J Surg Oncol. 2006;32:790–4.

    Article  PubMed  CAS  Google Scholar 

  9. Spillane AJ, Cheung BL, Winstanley J, Thompson JF. Lymph node ratio provides prognostic information in addition to AJCC N stage in patients with melanoma, even if the quality of surgery is standardized. Ann Surg. 2010; [Epub ahead of print].

  10. Spillane AJ, Winstanley J, Thompson JF. Lymph node ratio in melanoma: a marker of variation in surgical quality? Cancer. 2009;115:2384–7.

    Article  PubMed  Google Scholar 

  11. Xing Y, Badgwell BD, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, et al. Lymph node ratio predicts disease-specific survival in melanoma patients. Cancer. 2009;115:2505–13.

    Article  PubMed  Google Scholar 

  12. Rossi CR, Mocellin S, Pasquali S, Pilati P, Nitti D. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma. Ann Surg Oncol. 2008;15:310–5.

    Article  PubMed  Google Scholar 

  13. Mocellin S, Pasquali S, Rossi CR, Nitti D. Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis. J Natl Cancer Inst. 2010;102:493–501.

    Article  PubMed  CAS  Google Scholar 

  14. Hughes TM, Thomas JM. Combined inguinal and pelvic lymph node dissection for stage III melanoma. Br J Surg. 1999;86:1493–8.

    Article  PubMed  CAS  Google Scholar 

  15. van der Ploeg IM, Kroon BB, Valdes Olmos RA, Nieweg OE. Evaluation of lymphatic drainage patterns to the groin and implications for the extent of groin dissection in melanoma patients. Ann Surg Oncol. 2009;16:2994–9.

    Article  PubMed  Google Scholar 

  16. Badgwell B, Xing Y, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, et al. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma. Ann Surg Oncol. 2007;14:2867–75.

    Article  PubMed  Google Scholar 

  17. Chang SB, Askew RL, Xing Y, Weaver S, Gershenwald JE, Lee JE, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol. 2010;17:2764–72.

    Article  PubMed  Google Scholar 

  18. Guggenheim MM, Hug U, Jung FJ, Rousson V, Aust MC, Calcagni M, et al. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg. 2008;247:687–93.

    Article  PubMed  Google Scholar 

  19. Spillane AJ, Saw RP, Tucker M, Byth K, Thompson JF. Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Ann Surg. 2008;248:286–93.

    Article  PubMed  Google Scholar 

  20. Sabel MS, Griffith KA, Arora A, Shargorodsky J, Blazer DG 3rd, Rees R, et al. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery. 2007;141:728–35.

    Article  PubMed  Google Scholar 

  21. de Vries M, Hoekstra HJ, Hoekstra-Weebers JE. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma. Ann Surg Oncol. 2009;16:2840–7.

    Article  PubMed  Google Scholar 

  22. de Vries M, Vonkeman WG, van Ginkel RJ, Hoekstra HJ. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol. 2006;32:785–9.

    Article  PubMed  Google Scholar 

  23. Faries MB, Thompson JF, Cochran A, Elashoff R, Glass EC, Mozillo N. The Impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol. 2010;17:3324–9.

    Article  PubMed  Google Scholar 

  24. Moseley A, Piller N, Carati C. Combined opto-electronic perometry and bioimpedance to measure objectively the effectiveness of a new treatment intervention for chronic secondary leg lymphedema. Lymphology. 2002;35:136–43.

    PubMed  CAS  Google Scholar 

  25. Jacobs LK, Balch C, Coit DG. Inguinofemoral, iliac/obturator, and popliteal lymphadenectomy in patients with melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, Atkins MB, Thompson JF, editors. Cutaneous melanoma, St. Louis, MO: Quality Medical Publishing; 2009.

    Google Scholar 

  26. Spratt J. Groin dissection. J Surg Oncol. 2000;73:243–62.

    Article  PubMed  CAS  Google Scholar 

  27. Lanitis S, Tekkis PP, Sgourakis G, Dimopoulos N, Al Mufti R, Hadjiminas DJ. Comparison of skin-sparing mastectomy versus non-skin-sparing mastectomy for breast cancer: a meta-analysis of observational studies. Ann Surg. 251:632–9.

  28. Spratt JS. An update on incision for ilioinguinal lymph node dissection. Am J Surg. 1992;164:163–5; discussion 166.

    Article  PubMed  CAS  Google Scholar 

  29. Rapaport D, Stadelmann WK, Reintgen D. Inguinal lymphadenectomy. In Balch CM, Houghton AN, Sober AJ, Soong SJ, Atkins MB, Thompson JF, editors. Cutaneous melanoma. St. Louis, MO: Quality Medical Publishing; 2009. p. 269–80.

  30. Spillane AJ, Cheung BL, Stretch JR, Scolyer RA, Shannon KF, Quinn MJ, et al. Proposed quality standards for regional lymph node dissections in patients with melanoma. Ann Surg. 2009;249:473–80.

    Article  PubMed  Google Scholar 

  31. Ali-Khan AS, Crundwell M, Stone C. Inguinal lymphadenectomy combined with staging endoscopic pelvic node sampling for stage III melanoma. J Plast Reconstr Aesthet Surg. 2009;62:1063–7.

    Article  PubMed  CAS  Google Scholar 

  32. Jones WO, Cable RL, Gilling PJ. Laparoscopic pelvic lymphadenectomy for malignant melanoma. Aust N Z J Surg. 1995;65:765–7.

    Article  PubMed  CAS  Google Scholar 

  33. Picciotto F, Volpi E, Zaccagna A, Siatis D. Transperitoneal laparoscopical iliac lymphadenectomy for treatment of malignant melanoma. Surg Endosc. 2003;17:1536–40.

    Article  PubMed  CAS  Google Scholar 

  34. Schneider C, Brodersen JP, Scheuerlein H, Tamme C, Lippert H, Kockerling F. Combined endoscopic and open inguinal dissection for malignant melanoma. Langenbecks Arch Surg. 2003;388:42–7.

    PubMed  Google Scholar 

  35. Trias M, Targarona EM, Piulachs J, Balagué C, Bombuy E, Espert JJ, et al. Extraperitoneal laparoscopically assisted ilioinguinal lymphadenectomy for treatment of malignant melanoma. Arch Surg. 1998;133:272–4; discussion 275.

    Article  PubMed  CAS  Google Scholar 

  36. Delman KA, Kooby DA, Ogan K, Hsiao W, Master V. Feasibility of a novel approach to inguinal lymphadenectomy: minimally invasive groin dissection for melanoma. Ann Surg Oncol. 2010;17:731–7.

    Article  PubMed  Google Scholar 

  37. Delman KA, Kooby DA, Rizzo K, Organ K, Maithel SK, Master V. Growing experience with videoscopic inguinal lymphadenectomy (VIL): moving to better outcomes. Ann Surg Oncol. 2010;17:S15.

    Google Scholar 

  38. Hughes TM, A’Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg. 2000;87:892–901.

    Article  PubMed  CAS  Google Scholar 

  39. Sommariva A, Pasquali S, Rossi CR. Lymphadenectomy for melanoma: towards a videoscopic approach. Ann Surg Oncol. 2010 [Epub ahead of print].

Download references

Author information

Authors and Affiliations

  1. Sydney Medical School, The University of Sydney, Sydney, Australia

    Andrew John Spillane MD, FRACS

  2. Melanoma Institute Australia, Sydney, Australia

    Andrew John Spillane MD, FRACS, Monica Tucker RN & Sandro Pasquali MD

  3. The Mater Hospital, North Sydney, Australia

    Andrew John Spillane MD, FRACS

  4. Royal Prince Alfred Hospital, Camperdown, Australia

    Andrew John Spillane MD, FRACS

  5. Royal North Shore Hospital, St. Leonards, Australia

    Andrew John Spillane MD, FRACS

  6. Breast and Surgical Oncology at the Poche Centre, 40 Rocklands Road, North Sydney, Australia

    Monica Tucker RN

  7. University of Padova, Padova, Italy

    Sandro Pasquali MD

  8. Melanoma and Sarcomas Unit, Venetian Oncological Institute, Padova, Italy

    Sandro Pasquali MD

Authors
  1. Andrew John Spillane MD, FRACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Monica Tucker RN
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sandro Pasquali MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew John Spillane MD, FRACS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spillane, A.J., Tucker, M. & Pasquali, S. A Pilot Study Reporting Outcomes for Melanoma Patients of a Minimal Access Ilio-inguinal Dissection Technique Based on Two Incisions. Ann Surg Oncol 18, 970–976 (2011). https://doi.org/10.1245/s10434-010-1455-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1455-8

Keywords

Search

Navigation